Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology Share Issue/Capital Change 2026

Feb 25, 2026

3535_sha_2026-02-25_ae459b55-e847-4581-8705-dda0498f19a7.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Aqua Bio Technology ASA: Key information notice relating to reverse share split and change of ISIN

Aqua Bio Technology ASA: Key information notice relating to reverse share split and change of ISIN

Reference is made to the resolution by the annual general meeting of Aqua Bio

Technology ASA (the "Company") on 16 February 2026, regarding, inter alia, a

share consolidation (reverse share split) of the Company's shares in the ratio

of 50:1. Key information related to the reverse share split is set out below:

· Reverse split ratio: 50:1, i.e. fifty (50) old shares give one (1) new share

· Date on which the corporate action was made public: 26 January 2026

· Last day including right: 26 February 2026

· Ex-date: 27 February 2026

· Record Date: 2 March 2026

· Date of approval: 16 February 2026

Following completion of the share consolidation, the par value of the

Company's shares will be increased from NOK 0.10 to NOK 5.00. Shareholders who

do not own a number of shares which can be divided by 50 shall, in connection

with the reverse share split, have their shareholding rounded downwards, so

that the shareholder receives a whole number of shares. Fractional shares will

not be issued, and the shareholder will not receive any compensation for the

rounding. The fractional shares will be added together to whole shares and

will be sold at Euronext Expand. The net proceeds from such sale shall be

donated to a charitable purpose as determined by the Board of Directors.

In connection with the reverse share split, the Company's shares will be

transferred to a new ISIN. Key information for the change of ISIN is set out

below:

· Issuer: Aqua Bio Technology ASA

· Previous ISIN: NO 001 0307135

· New ISIN: NO 001 3735894

· Date of ISIN change: 27 February 2026

Contacts

Kristian Flaten

CEO & CFO

Aqua Bio Technology ASA

Phone: +47 9509 2322

Email: [email protected]

About Us

Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in

skincare and nonfood. The group has distribution towards B2C and B2B, and

offers freight, customs, and logistics services. The group also develops

sustainable biotechnology for use in skincare products. Aqua Bio Technology is

listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §

5-12 and MAR Article 17. The information was submitted for publication,

through the agency of the contact persons set out above, at 2026-02-25 07:57

CET.